| Financial Year |
March 31 2023 |
| Monetary Funds |
1,580,415,841.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
105,158,194.16 |
| Advances to Suppliers |
259,289,008.22 |
| Other Receivables |
64,921,291.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,465,098,574.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
523,734,375.00 |
| Other Current Assets |
272,961,418.94 |
| Total Current Assets |
5,833,062,134.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
975,523,262.11 |
| Investment Properties |
-- |
| Fixed Assetes |
11,988,540,927.79 |
| Under-construction Projects |
641,435,180.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
321,557,073.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
251,037,163.98 |
| Other Non-Current Assets |
1,165,075,967.23 |
| Sub-Total of Non-Current Assets |
15,708,659,032.59 |
| Total Assets |
21,541,721,166.99 |
| Short-Term Loans |
1,250,789,697.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,657,535,030.09 |
| Accounts Payable |
4,270,847,067.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,866,146.33 |
| Taxes Payable |
24,227,170.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
122,244,596.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,154,436.31 |
| Other Current Liabilities |
138,748,584.02 |
| Sub-Total of Current Liabilities |
10,619,098,052.61 |
| Long-term Loans |
1,117,012,747.41 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
43,600,350.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,758,443,900.15 |
| Total Liabilities |
12,377,541,952.76 |
| Paid-In Capital(Or Share Stock) |
2,423,845,590.00 |
| Capital Surplus |
3,162,830,678.21 |
| Surplus Reserve |
1,163,873,556.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,423,630,758.96 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,164,179,214.23 |
| Owner's Equity（Stockholder's Equity） |
9,164,179,214.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,541,721,166.99 |
